4.6 Article

Should the Splenic Vein Be Preserved-Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma

Wilson Luiz da costa et al.

Summary: This study evaluates the association between staging concordance, treatment sequencing, and response to neoadjuvant therapy (NAT) in pancreatic ductal adenocarcinoma (PDAC) patients. The study finds that NAT is associated with improved survival for PDAC patients, particularly for those with more advanced disease.

ANNALS OF SURGERY (2022)

Article Surgery

Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery

Shugo Mizuno et al.

Summary: The study revealed that dividing the splenic vein during pancreaticoduodenectomy increases the incidence of variceal formation and bleeding, as well as causing thrombocytopenia in patients. These findings suggest the importance of careful consideration of splenic vein management during surgery.

ANNALS OF SURGERY (2021)

Article Surgery

The clinical impact of splenic artery ligation on the occurrence of digestive varices after pancreaticoduodenectomy with combined portal vein resection: a retrospective study in two institutes

Daisaku Yamada et al.

Summary: Pancreaticoduodenectomy (PD) concomitant with portal vein resection (PVR) often leads to digestive varices with an occurrence rate of 30-50%. Splenic artery (SpA) ligation during PD-PVR significantly decreases the development of digestive varices without causing clinically significant complications.

LANGENBECKS ARCHIVES OF SURGERY (2021)

Review Oncology

Sinistral Portal Hypertension after Pancreaticoduodenectomy with Splenic Vein Resection: Pathogenesis and Its Prevention

Yoshihiro Ono et al.

Summary: In pancreaticoduodenectomy (PD) for pancreatic cancer, extensive portal vein resection may sometimes be necessary for curative resection, including porto-mesenterico-splenic confluence (PMSC). However, long-term survival patients may develop sinistral portal hypertension as a late-onset postoperative complication.

CANCERS (2021)

Article Oncology

Pancreatic Adenocarcinoma, Version 2.2021

Margaret A. Tempero et al.

Summary: Pancreatic cancer is the fourth leading cause of cancer-related death in the United States, with a major challenge being advanced disease at diagnosis. While survival rates have not significantly changed, newer treatments, including targeted therapies, offer hope for patients. The manuscript focuses on systemic therapy approaches for locally advanced and metastatic disease.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Gastroenterology & Hepatology

What's new in portal hypertension?

Ezequiel Mauro et al.

LIVER INTERNATIONAL (2020)

Article Oncology

FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma

Eran Sadot et al.

ANNALS OF SURGICAL ONCOLOGY (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Changes of portosystemic collaterals and splenic volume on CT after liver transplantation and factors influencing those changes

Se Hyung Kim et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2008)

Article Immunology

Venous complications after orthotopic liver transplantation

H Karakayali et al.

TRANSPLANTATION PROCEEDINGS (2006)